Effects of individual risk factors on the residual risk of cardiovascular events in a population of treated Chinese patients with hypertension: data from the Felodipine Event Reduction (FEVER) study
- 1 October 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 28 (10) , 2016-2025
Abstract
Background and objectives The added cardiovascular risk conferred by risk factors or diseases accompanying hypertension has been investigated in Caucasian patients, and much less is known in Chinese patients. Furthermore, the residual risk persisting in hypertensive patients, despite blood pressure (BP) reduction, due to accompanying conditions has never been explored in Chinese, and whether they differ from Caucasians under this respect is unknown. Methods Felodipine Event Reduction (FEVER) study randomized 9711 Chinese hypertensive patients to more or less intense antihypertensive treatment for 40 months, with outcome monitoring. The present analyses provide information on the role that baseline presence of individual risk factors has in increasing outcome probability despite BP control. Risk ratios were calculated using Cox proportional hazard models, adjusted for a large number of baseline variables, except the one under examination, and also adjusted for on-treatment systolic and diastolic BP. Results Male sex, older age, diabetes and cardiovascular disease were accompanied by a significantly higher incidence of cardiovascular events (risk ratios 1.41-1.86 according to risk factor), stroke (risk ratios 1.42-1.72), cardiac events (risk ratios 1.40-2.70), all-cause death (risk ratios 1.51-2.16) and cardiovascular death (risk ratios 1.61-2.02). Higher baseline systolic BP and smoking conferred a significantly increased risk of cardiovascular events and strokes. Higher cholesterol was not found to increase any cardiovascular outcome. The same was the case for electrocardiographic left-ventricular hypertrophy and isolated systolic hypertension. Conclusions A number of additional risk factors increased the residual risk of Chinese hypertensive patients despite effective antihypertensive treatment as much as described in Caucasians. High serum cholesterol was an exception: whether this is a Chinese characteristic or a more general phenomenon remains to be investigated. J Hypertens 28: 2016-2025 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.Keywords
This publication has 29 references indexed in Scilit:
- Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force documentJournal Of Hypertension, 2009
- Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the Asia–Pacific regionJournal Of Hypertension, 2007
- 2007 Guidelines for the Management of Arterial HypertensionJournal Of Hypertension, 2007
- Estimation of 10-Year Risk of Fatal and Nonfatal Ischemic Cardiovascular Diseases in Chinese AdultsCirculation, 2006
- Joint Effects of Systolic Blood Pressure and Serum Cholesterol on Cardiovascular Disease in the Asia Pacific RegionCirculation, 2005
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertensionJournal Of Hypertension, 2003
- Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projectEuropean Heart Journal, 2003
- The Prospective Cardiovascular Münster (PROCAM) study: Prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart diseaseAmerican Heart Journal, 1988
- The Effect of Treatment on Mortality in Mild HypertensionNew England Journal of Medicine, 1982